In conclusion, we observed striking similarities in expression patterns of HSPCs from sporadic human JMML patients with an activating SHP2 mutation and HSPCs from an engineered zebrafish model with an activating NS-associated mutation in Shp2. The gene discussed is PTPN11; the disease is juvenile myelomonocytic leukemia.